Drug Shortage Report for TEVA-BUPROPION XL
Report ID | 119889 |
Drug Identification Number | 02439654 |
Brand name | TEVA-BUPROPION XL |
Common or Proper name | BUPROPION XL 150MG SR TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 150MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 90's & 500's |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-08 |
Estimated end date | 2020-08-31 |
Actual end date | 2020-08-26 |
Shortage status | Resolved |
Updated date | 2020-08-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-08-27 | French | Compare |
v3 | 2020-08-27 | English | Compare |
v2 | 2020-07-09 | French | Compare |
v1 | 2020-07-09 | English | Compare |
Showing 1 to 4 of 4